New EU active substance non-approval decision Non-approval of active substance/product type combination not included in the review programme. Following the evaluation of the application for approval under EU BPR, a decision has been taken not to approve the following active substance/product type combination. This will affect NI: 5-chloro-2-methyl-2H-isothiazol-3-one (CIT) (CAS 26172-55-4 EC 247-500-7) in product type 6
Ben KempApril 11, 2025